Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T22:28:22.553Z Has data issue: false hasContentIssue false

Drug treatment and psychotherapy of premature ejaculation

Published online by Cambridge University Press:  16 April 2020

M.D. Waldinger*
Affiliation:
Department of Psychiatry and Neurosexology, Hagahospital Leyenburg, Leyenburg, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Drug treatment of lifelong premature ejaculation (PE) consists of daily use of SSRIs, particularly paroxetine 20mg and sertraline 50-100mg, on-demand use of clomipramine 20-50mg (3-6 hour prior to coitus) and/or topical anesthetics, such as lidocaine and prilocaine [1].

PE is a common male sexual complaint in approximately 20-40% of men. However, not all these men require treatment. PE has been distinguished in Lifelong and Acquired PE. Recently, two other PE syndromes have been classified [2,3]. In “Normal Variable PE” the occurrence of early ejaculation is rather inconsistent and should be regarded as a normal pattern of ejaculatory performance [2]. In “Premature-like Ejaculatory Dysfunction” men complain of an early ejaculation while the duration of the IELT is in the normal range (about 5 minutes) or even longer (5-10 min) [3]. The four PE syndromes require different forms of treatment. Lifelong PE should be treated with medication. Acquired PE needs medication and/or psychotherapy. Normal Variable PE requires psycho-education and Premature-like PE requires either psychotherapy, psycho-education or counselling.

Type
S04. Symposium: The New Role of (Neuro) Psychiatry in Sexual Medicine
Copyright
Copyright © European Psychiatric Association 2007

References

Waldinger, M.D., Olivier, B.Utility of selective serotonin reuptake inhibitors in premature ejaculation. Current Opinion in Investigational Drugs 2004; 5: 743747Google ScholarPubMed
Waldinger, M.D., Schweitzer, D.H.Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part II: Proposals for DSM-V and ICD-11. J Sex Med 2006; 3: 69370510.1111/j.1743-6109.2006.00276.xCrossRefGoogle Scholar
Waldinger, M.D.The need for a revival of psychoanalytic investigations into premature ejaculation. JMHG 2006; 3: 390396Google Scholar
Submit a response

Comments

No Comments have been published for this article.